We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$452M
AUM Growth
+$130M
Cap. Flow
-$18.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.03M
2
OSPN icon
OneSpan
OSPN
+$2.96M
3
ATEX icon
Anterix
ATEX
+$2.79M
4
CALX icon
Calix
CALX
+$2.73M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.72M

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.54M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.44M
3
TDOC icon
Teladoc Health
TDOC
+$3.2M
4
KRYS icon
Krystal Biotech
KRYS
+$3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 21.89%
3 Consumer Discretionary 16.2%
4 Industrials 10.05%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUNA
351
DELISTED
Luna Innovations Incorporated
LUNA
– –
-434,929
Closed -$2.67M
CEMI
352
DELISTED
Chembio diagnostics, Inc.
CEMI
– –
-119,666
Closed -$613K
11 12 13 14
15

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return

EAM Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.

  • EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
  • EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
  • EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
  • EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
  • EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
  • EAM Investors opened 147 new positions and closed 97 in Q2 2020.
  • EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.